Sept. 4, 2025

CMS recently released Change Request 14194, which contains coding revisions to various National Coverage Determinations (NCD) relevant to radiology.

Modifications include the following NCDs:

NCD 220.4 Mammograms

Effective Oct. 1, Medicare Administrative Contractors (MACs) are instructed to update coverage criteria by adding the following ICD-10 diagnosis codes:

  • C50.A1 – Malignant inflammatory neoplasm of right breast
  • C50.A2 – Malignant inflammatory neoplasm of left breast
  • Z84.A – Family history of exposure to diethylstilbestrol
  • Z91.B – Personal risk factor of exposure to diethylstilbestrol

NCD 220.6.17 Positron Emission Tomography (FDG) for Oncologic Conditions

  • CMS instructs MACs to add ICD-10 diagnosis codes C50.A1, C50.A2, Z84.A effective Oct. 1.

NCD 220.13 Percutaneous Image-Guided Breast Biopsy

  • CMS instructs MACs to add ICD-10 diagnosis codes C50.A1 and C50.A2 effective Oct. 1.

See Change Request 14194 and MLN Matters article MM14194 for further details, including a full list of affected NCDs.

For more information, please contact Maria Tran, American College of Radiology® Director of Economic Policy.


Related ACR News

  • CMS Releases 2026 Medicare Physician Fee Schedule Final Rule

    CMS released the 2026 MPFS final rule Oct. 31. ACR prepared an initial summary about impact on imaging.

    Read more
  • Massachusetts Legislature Updates Prior Authorization Bill

    Massachusetts HB 4616 aims to streamline prior authorization, boost transparency, and study its impact on care access and costs.

    Read more
  • ACR Responds to RFI on AI Regulatory Reform

    ACR urged the White House to enhance AI oversight and payment policies to support safe, effective, and reimbursable clinical AI use.

    Read more